Nephros (NEPH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.65, +3.99% vs the prior close of $3.51.
- Volume 45.99K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NEPH jumps 4.0% to $3.65. Closed at $3.65, +3.99% vs the prior close of $3.51. Day range $3.40–$3.65, opened at $3.45.
NEPH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NEPH jumps 4.0% to $3.65
- Closed at $3.65, +3.99% vs the prior close of $3.51. Day range $3.40–$3.65, opened at $3.45.
- Volume was 45.99K shares, 1.3x its 50-day average of 34.49K.
- Price is -11.0% vs its 50-day average ($4.10) and -2.3% vs its 200-day average ($3.74).
- 52-week range $2.66–$6.42; today's close sits at 26% of that range, 43.1% below the 52-week high.
Oct 15, 2026 — NEPH ends flat (-0.3%) to $3.51
- Closed at $3.51, -0.28% vs the prior close of $3.52. Day range $3.41–$3.66, opened at $3.54.
- Volume was 26.20K shares, 0.8x its 50-day average of 34.01K.
- Price is -14.4% vs its 50-day average ($4.10) and -6.2% vs its 200-day average ($3.74).
- 52-week range $2.66–$6.42; today's close sits at 23% of that range, 45.3% below the 52-week high.
Oct 14, 2026 — NEPH dips 1.9% to $3.52
- Closed at $3.52, -1.95% vs the prior close of $3.59. Day range $3.33–$3.57, opened at $3.46.
- Volume was 9.20K shares, 0.3x its 50-day average of 33.95K — lighter than usual.
- Price is -14.2% vs its 50-day average ($4.10) and -6.1% vs its 200-day average ($3.75).
- 52-week range $2.66–$6.42; today's close sits at 23% of that range, 45.2% below the 52-week high.
- SEC filings that day: DEF 14A.
Oct 13, 2026 — NEPH rises 0.6% to $3.59, 5 up days in a row
- Closed at $3.59, +0.56% vs the prior close of $3.57. Day range $3.42–$3.60, opened at $3.53.
- Volume was 20.60K shares, 0.6x its 50-day average of 34.70K — lighter than usual.
- Price is -12.5% vs its 50-day average ($4.10) and -4.4% vs its 200-day average ($3.76).
- 52-week range $2.66–$6.42; today's close sits at 25% of that range, 44.1% below the 52-week high.
- That makes 5 straight gains.
- SEC filings that day: 8-K.
Oct 12, 2026 — NEPH rises 1.1% to $3.57 on 2.0x normal volume
- Closed at $3.57, +1.13% vs the prior close of $3.53. Day range $3.46–$3.70, opened at $3.61.
- Volume was 67.00K shares, 2.0x its 50-day average of 33.44K — unusually heavy trading.
- Price is -13.0% vs its 50-day average ($4.10) and -5.2% vs its 200-day average ($3.76).
- 52-week range $2.66–$6.42; today's close sits at 24% of that range, 44.4% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — NEPH jumps 7.3% to $3.53, 3 up days in a row
- Closed at $3.53, +7.29% vs the prior close of $3.29. Day range $3.31–$3.54, opened at $3.33.
- Volume was 35.80K shares, 1.1x its 50-day average of 32.93K.
- Price is -13.9% vs its 50-day average ($4.10) and -6.3% vs its 200-day average ($3.77).
- 52-week range $2.66–$6.42; today's close sits at 23% of that range, 45.0% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — NEPH rises 2.8% to $3.29 on 4.4x normal volume
- Closed at $3.29, +2.81% vs the prior close of $3.20. Day range $3.11–$3.30, opened at $3.16.
- Volume was 135.60K shares, 4.4x its 50-day average of 30.56K — unusually heavy trading.
- Price is -19.7% vs its 50-day average ($4.10) and -12.9% vs its 200-day average ($3.78).
- 52-week range $2.66–$6.42; today's close sits at 17% of that range, 48.8% below the 52-week high.
Oct 7, 2026 — NEPH jumps 6.0% to $3.20
- Closed at $3.20, +5.96% vs the prior close of $3.02. Day range $3.05–$3.54, opened at $3.08.
- Volume was 46.60K shares, 1.5x its 50-day average of 30.16K.
- Price is -21.9% vs its 50-day average ($4.10) and -15.4% vs its 200-day average ($3.78).
- 52-week range $2.66–$6.42; today's close sits at 14% of that range, 50.2% below the 52-week high.
Oct 6, 2026 — NEPH slides 14.9% to $3.02, a 3-month low on 6.7x normal volume
- Closed at $3.02, -14.93% vs the prior close of $3.55. Day range $3.01–$3.79, opened at $3.57.
- Volume was 179.80K shares, 6.7x its 50-day average of 26.73K — unusually heavy trading.
- Price is -26.4% vs its 50-day average ($4.10) and -20.4% vs its 200-day average ($3.79).
- 52-week range $2.66–$6.42; today's close sits at 10% of that range, 53.0% below the 52-week high.
- That makes 7 straight losses.
Oct 5, 2026 — NEPH slides 3.3% to $3.55, a 1-month low, 6 down days in a row
- Closed at $3.55, -3.27% vs the prior close of $3.67. Day range $3.55–$3.74, opened at $3.67.
- Volume was 17.80K shares, 0.7x its 50-day average of 26.52K.
- Price is -13.7% vs its 50-day average ($4.11) and -6.7% vs its 200-day average ($3.80).
- 52-week range $2.66–$6.42; today's close sits at 24% of that range, 44.7% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — NEPH ends flat (+0.0%) to $3.67, 5 down days in a row
- Closed at $3.67, +0.00% vs the prior close of $3.67. Day range $3.63–$3.89, opened at $3.71.
- Volume was 16.90K shares, 0.6x its 50-day average of 26.27K.
- Price is -10.8% vs its 50-day average ($4.11) and -3.7% vs its 200-day average ($3.81).
- 52-week range $2.66–$6.42; today's close sits at 27% of that range, 42.8% below the 52-week high.
- That makes 5 straight losses.
NEPH latest news & SEC filings
Every SEC filing by or about NEPH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.08 — Set shareholder nomination dates.
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wexford Capital Lp & Wexford Gp Llc & Davidson Charles E & Jacobs Joseph reported an other transaction of 3,355,111 shares on Sep 14, 2026; now holds 189,377
- Wexford Capital Lp & Wexford Gp Llc & Davidson Charles E & Jacobs Joseph reported an other transaction of 22,710 shares at $3.95 (≈$89.70K) on Sep 14, 2026; now holds 166,667
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Amron Arthur H & Amron Holdings Llc reported an other transaction of 17,749 shares on Sep 14, 2026; now holds 158,623
- Amron Arthur H & Amron Holdings Llc reported an other transaction of 2,836 shares on Sep 14, 2026; now holds 2,836
- Amron Arthur H & Amron Holdings Llc reported an other transaction of 22,710 shares at $3.95 (≈$89.70K) on Sep 14, 2026; now holds 25,546
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $6.02M (prior year $4.42M) (+36.2% vs Jun 30, 2025)
- Net income: $1.20M (prior year $237.00K) (+405.1% vs Jun 30, 2025)
- Diluted EPS: $0.11 (prior year $0.02) (+450.0% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade NEPH
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Aug 11, 2025, May 8, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.55% (largest 14.9%). That is a volatile stock.
- Liquidity: about 40.13K shares (≈$146.49K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.65 vs a range of $2.66–$6.42 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026; 10-Q Aug 10, 2026; 8-K Aug 6, 2026.
- Share count: 10.86M shares outstanding (Aug 7, 2026), +2.4% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
NEPH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.45 | 3.65 | 3.40 | 3.65 | 45.99K |
| Oct 15, 2026 | 3.54 | 3.66 | 3.41 | 3.51 | 26.20K |
| Oct 14, 2026 | 3.46 | 3.57 | 3.33 | 3.52 | 9.20K |
| Oct 13, 2026 | 3.53 | 3.60 | 3.42 | 3.59 | 20.60K |
| Oct 12, 2026 | 3.61 | 3.70 | 3.46 | 3.57 | 67.00K |
| Oct 9, 2026 | 3.33 | 3.54 | 3.31 | 3.53 | 35.80K |
| Oct 8, 2026 | 3.16 | 3.30 | 3.11 | 3.29 | 135.60K |
| Oct 7, 2026 | 3.08 | 3.54 | 3.05 | 3.20 | 46.60K |
| Oct 6, 2026 | 3.57 | 3.79 | 3.01 | 3.02 | 179.80K |
| Oct 5, 2026 | 3.67 | 3.74 | 3.55 | 3.55 | 17.80K |
| Oct 2, 2026 | 3.71 | 3.89 | 3.63 | 3.67 | 16.90K |
| Oct 1, 2026 | 3.71 | 3.80 | 3.50 | 3.67 | 46.50K |
| Sep 30, 2026 | 3.89 | 3.89 | 3.71 | 3.71 | 15.60K |
| Sep 29, 2026 | 4.08 | 4.27 | 3.83 | 3.89 | 29.20K |
| Sep 28, 2026 | 4.24 | 4.37 | 4.00 | 4.03 | 53.60K |
| Sep 25, 2026 | 4.12 | 4.33 | 4.07 | 4.23 | 9.30K |
| Sep 24, 2026 | 4.07 | 4.24 | 4.07 | 4.14 | 1.70K |
| Sep 23, 2026 | 4.17 | 4.32 | 4.12 | 4.29 | 6.70K |
| Sep 22, 2026 | 4.26 | 4.30 | 4.17 | 4.17 | 17.10K |
| Sep 21, 2026 | 4.37 | 4.40 | 4.22 | 4.38 | 21.50K |
About Nephros
Nephros (NEPH) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SOUTH ORANGE, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1196298.
NEPH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Arthur H Amron | Director | Sep 16, 2026 |
| Holdings Llc Amron | Director | Sep 16, 2026 |
| Lisa Marie Nettis | Director | Nov 13, 2025 |
| Oliver J. Spandow | Director | Nov 13, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert R. Jr. Banks | President and CEO | Mar 25, 2026 |
| Judy Krandel | Chief Financial Officer | Mar 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NEPH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $18.79M | $1.19M | 0.11 | $1.65M |
| Dec 31, 2024 | $14.16M | $74.00K | 0.01 | $-492.00K |
| Dec 31, 2023 | $14.24M | $-1.57M | -0.15 | $827.00K |
| Dec 31, 2022 | $9.97M | — | -0.73 | $-3.23M |
| Dec 31, 2021 | $10.22M | $-3.87M | — | $-1.42M |
Latest balance sheet: total assets $15.77M, total liabilities $3.80M, cash $4.70M (as of Jun 30, 2026).
NEPH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $3.59 |
| May 7, 2026 | 8-K Item 2.02 (results) | $3.23 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $4.49 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.99 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $1.43 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $1.63 |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 7, 2024 | 8-K Item 2.02 (results) | — |
| Aug 9, 2023 | 8-K Item 2.02 (results) | — |
| Apr 4, 2023 | 8-K Item 2.02 (results) | — |
| Mar 8, 2023 | 8-K Item 2.02 (results) | — |
| Jan 11, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NEPH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.